Highmark Enters Outcomes-based Contract for Anti-inflammatory Drug Cimzia
Highmark announced today that it entered into an outcomes-based agreement with UCB Inc. for its tumor necrosis factor blocking medication [...]
New Data Shows Part D Savings Took Hit Due to Price Increases on RA Drugs
A new study published in JAMA Network Open suggests patients took a big hit on savings for RA drugs under [...]
Advertisement
